Survey is now closed. We had an awesome response - thanks for your support! Orion Pharma, a pharmaceutical company based in Finland, would like to gather information about Raynaud’s from people suffering from this condition. The data gathered in the research will be used by Orion to help develop a new class of medication for Raynaud's patients.
After knowing for years that something was wrong but not having enough to go on to prove it, my pediatrician suspected that my then 5 year old had Juvenile Arthritis. It took a long time to diagnose her- almost a year! Eventually she was also diagnosed with scleroderma and mixed connective tissue disease. Her new
After my friend with Raynaud’s told me she had some success with acupuncture, I decided to give my own Raynaud's journey with acupuncture a try.
Drug Intended for the Treatment of Raynaud's Phenomena, Secondary to Systemic Sclerosis SAN DIEGO, April 13, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) announced today its filing with the U.S. Food & Drug Administration ("FDA") requesting orphan drug designation for RayVa™, the Company's drug candidate indicated for the treatment of Raynaud's
We’ve heard from a manufacturer who has been developing a heated steering wheel cover and it’s great news: The prototype is ready and it’s “everything we wanted it to be!” We’ll be seeing the prototype later this month, and if all goes well, the product may be available for purchase in time for next fall. In
